Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.85 |
| ▸ | GNA15 | P30679 | 1/20 | 0.69 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.69 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.69 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.69 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16123744 | 0.93 | FFAR1 (0.74) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110447 | 0.93 | FFAR1 (0.83) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL15125747 | 0.93 | FFAR1 (0.74) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL13110442 | 0.93 | FFAR1 (0.82) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123789 | 0.92 | FFAR1 (0.73) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL1633142 | 0.92 | FFAR1 (1.00) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123734 | 0.92 | FFAR1 (0.72) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16684804 | 0.91 | FFAR1 (0.72) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123792 | 0.91 | FFAR1 (0.71) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 | |
| SCHEMBL16123739 | 0.91 | FFAR1 (0.71) | FFAR1GNA15SLC10A1ABCC2SLCO1B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |
| US-7820837-B2 | ethyl {6-[(3-phenoxybenzyl)oxy]-3,4-dihydronaphthalen-1-yl}acetate; having a GPR40 receptor function modulating action and being useful as an insulin secretagogue or a pharmaceutical agent for the prophylaxis or treatment of diabetes | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-10-26 | — | — | US | disclosed |